Drug Trial Radar · NCT01307020
Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain
Last checked: Nov 20, 2026Latest source record: Aug 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
745
Actual
Start
Feb 2011
Primary completion
Oct 2011
Study completion Oct 2011
Sponsor
- Lead sponsor
- Menarini GroupIndustry
- Sponsor type
- Industry
- Collaborators
- PRA Health Sciences
- First posted
- Mar 2, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the analgesic efficacy of Dexketoprofen Trometamol and Tramadol Hydrochloride given in combinations and the analgesic efficacy of each single component in comparison to placebo on moderate to severe pain following impacted third mandibular molar tooth extraction. Ibuprofen will be used as an active control to validate the pain model.
Conditions
- Pain
Interventions
Dexketoprofen TrometamolDrug
Dexketoprofen Trometamol low dose, oral film-coated table, once
Dexketoprofen TrometamolDrug
Dexketoprofen Trometamol high dose, oral film-coated table, once
Tramadol HydrochlorideDrug
Tramadol Hydrochloride low dose, oral film-coated table, once
Tramadol HydrochlorideDrug
Tramadol Hydrochloride high dose, oral film-coated table, once
IbuprofenDrug
Ibuprofen 400 mg, oral film-coated table, once
PlaceboDrug
Placebo, oral film-coated table, once
Dexketoprofen Trometamol + Tramadol HydrochlorideDrug
DKP-TRIS low dose - TRAM.HCl low dose, oral film-coated table, once
Dexketoprofen Trometamol + Tramadol HydrochlorideDrug
DKP-TRIS low dose - TRAM.HCl high dose, oral film-coated table, once
Dexketoprofen Trometamol + Tramadol HydrochlorideDrug
DKP-TRIS high dose - TRAM.HCl low dose, oral film-coated tablet, once
Dexketoprofen Trometamol + Tramadol HydrochlorideDrug
DKP-TRIS high dose - TRAM.HCl high dose, oral film-coated tablet, once
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients Achieving at Least 50 % of the Theoretical Maximum Total Pain Relief Score at 6 Hours Post-dosing.Time frame: 6 hours
Locations
16 sites in 6 countries. Site status is shown where the registry gives one.
Klinik und Polickinik für Mund-Kiefer-Gesichtschirurgie/Plastische Operationen Greifswald
Greifswald, Mecklenburg-Vorpommern, Germany
Klinik für Mund-, Kiefer- und Gesichtschirurgie, Universitätsklinikum Schleswig Holstein, Campus Kiel
Kiel, Schleswig-Holstein, Germany
Dr Tóth Bagi Zoltán Fogászati Rendeloje
Budapest, Budapest, Hungary
Centro di Farmacologia Clinica per la Sperimentazione dei Farmaci
Pisa, Pisa, Italy
Centro di Ricerche Cliniche di Verona Srl. Policlinico G.B.Rossi
Verona, Verona, Italy
Gabinet Stomatologiczny Andrzej Wojtowicz AW Clinic
Warsaw, Masovian Voivodeship, Poland
Dental Service spólka jawna
Warsaw, Masovian Voivodeship, Poland
Hospital Médico Quirúrgico de Conxo
Santiago de Compostela, A Coruña, Spain
Facultad de Odontología. Departamento de Cirugía Bucal y Maxilofacial, University of Barcelona - Bellvitge Institute for Biomedical Research (IDIBELL)
L'Hospitalet de Llobregat, Barcelona, Spain
Universidad Complutense de Madrid
Madrid, Madrid, Spain
Departamento de Estomatología, Facultad de Odontología. Universidad de Sevilla
Seville, Sevilla, Spain
Departament d'Estomatologia, Clínica Odontològica, Universidad de Valencia - Fundació Lluís Alcanyís
Valencia, Valencia, Spain
Hospital General Universitario de Valencia
Valencia, Valencia, Spain
The School of Dentistry, College of Medical and Dental Sciences, University of Birmingham
Birmingham, England, United Kingdom
University Dental School Manchester
Manchester, England, United Kingdom
University Dental Hospital
Cardiff, Wales, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.